Amgen (AMGN) Tops Q1 EPS by 16c
Tweet
Share
E-mail_58cbc46cd3c33.jpg)
Get Alerts AMGN Hot Sheet
Price: $414.61 +2.11%
Revenue Growth %: +5.1%
Financial Fact:
Other revenues: 295M
Today's EPS Names:
OCCI, IPX, ALZN, More
Revenue Growth %: +5.1%
Financial Fact:
Other revenues: 295M
Today's EPS Names:
OCCI, IPX, ALZN, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q1 EPS of $3.98, $0.16 better than the analyst estimate of $3.82. Revenue for the quarter came in at $6.1 billion versus the consensus estimate of $6.12 billion.
GUIDANCE:
Amgen sees FY 2023 EPS of $17.60-$18.70, versus the consensus of $17.72. Amgen sees FY 2023 revenue of $26.2-27.3 billion, versus the consensus of $26.7 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
- Freedom Broker Starts Autoliv, Inc. (ALV) at Buy
- Bernstein sees downside risk to Apple's December quarter results
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
